Recent media attention has focused on the possibility that long-term proton pump inhibitor (PPI) therapy may lead to an increased risk of hip fracture.
Overdose with venlafaxine may be associated with a higher risk of fatal outcome compared to overdose with selective serotonin reuptake inhibitor antidepressants, but lower than that seen with tricyclic antidepressants.
Dr. Robert Ouellet, president of the CMA, today announced the CMA's intention to begin an international fact-finding mission examining ideas for health care reform and renewal in several European countries.
Celgene's Revlimid (lenalidomide 15 mg and 25 mg capsules) is now indicated for the treatment of multiple myeloma (in combination with dexamethasone) in patients who have received at least one prior therapy.
